Spots Global Cancer Trial Database for Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis
Official Title: Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis
Study ID: NCT01058317
Conditions
Interventions
Study Description
Brief Summary: Juvenile onset recurrent respiratory papillomatosis (JORRP) is a rare, difficult to treat, benign tumor of the pediatric airway. Current therapy is mainly surgical, but in a significant portion of patients adjuvant therapy is required to control the disease process. Although multiple adjuvant medical therapies have been tried, success has been limited. We have seen some success in a limited amount of patients using orally administered propranolol. Our goal is to enroll a larger cohort of patients to determine the effectiveness of propranolol as an adjuvant therapy for JORRP.
Detailed Description:
Eligibility
Minimum Age: 1 Year
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Christopher Hartnick, MD
Affiliation: Massachusetts Eye and Ear Infirmary
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
